Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.56NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.49NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.49NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.49NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBL.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBL.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FR.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.18.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.18.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.18.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.23.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.23.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.23.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.21.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.21.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.21.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used